Cargando…
Mammalian target of rapamycin inhibition attenuates myocardial ischaemia–reperfusion injury in hypertrophic heart
Pathological cardiac hypertrophy aggravated myocardial infarction and is causally related to autophagy dysfunction and increased oxidative stress. Rapamycin is an inhibitor of serine/threonine kinase mammalian target of rapamycin (mTOR) involved in the regulation of autophagy as well as oxidative/ni...
Autores principales: | Ma, Lei‐Lei, Ma, Xin, Kong, Fei‐Juan, Guo, Jun‐Jie, Shi, Hong‐Tao, Zhu, Jian‐Bing, Zou, Yun‐Zeng, Ge, Jun‐Bo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5824378/ https://www.ncbi.nlm.nih.gov/pubmed/29314656 http://dx.doi.org/10.1111/jcmm.13451 |
Ejemplares similares
-
Hypertrophic Preconditioning Attenuates Myocardial Ischaemia‐Reperfusion Injury by Modulating SIRT3‐SOD2‐mROS‐Dependent Autophagy
por: Ma, Lei‐Lei, et al.
Publicado: (2021) -
Hypertrophic preconditioning cardioprotection after myocardial ischaemia/reperfusion injury involves ALDH2-dependent metabolism modulation
por: Ma, Lei-Lei, et al.
Publicado: (2021) -
Inhibition of adenosine kinase attenuates myocardial ischaemia/reperfusion injury
por: Wang, Wenjun, et al.
Publicado: (2021) -
Reperfusion Therapy with Rapamycin Attenuates Myocardial Infarction through Activation of AKT and ERK
por: Filippone, Scott M., et al.
Publicado: (2017) -
Mechanisms and prognostic impact of myocardial ischaemia in hypertrophic cardiomyopathy
por: Coleman, James A., et al.
Publicado: (2023)